Impact of Heart Failure Guideline Publication on Medicare Drug Coverage Policies: A Quasi‐Experimental Analysis

Coverage barriers to ARNI and SGLT2i were common and changed only slightly after publication of Value Statements in HF guidelines. There is a critical need for robust strategies to improve access to life-saving HF medications.